McDermott Will & Emery advised AMILI on the deal. AMILI, a Singapore-based precision gut microbiome startup, raised US$10.5 million in its over-subscribed Series A funding led...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
